Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)

ClinicalTrials.gov ID: NCT00706082

Public ClinicalTrials.gov record NCT00706082. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Two-stage Prospective Observational Cohort Study in Scleroderma Patients to Evaluate Screening Tests and the Incidence of Pulmonary Arterial Hypertension and Pulmonary Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A two-stage prospective observational cohort study in scleroderma patients to evaluate screening tests and the incidence of pulmonary arterial hypertension and pulmonary hypertension

Study identification

NCT ID
NCT00706082
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Actelion
Industry
Enrollment
490 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2008 (Type not available)
Primary completion
Nov 2011 (Actual)
Completion
Mar 2012 (Actual)
Last update posted
Jun 25, 2012

2008 – 2012

United States locations

U.S. sites
23
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
University of Alabama at Birmingham, 311 THT Birmingham Alabama 35294 —
UCLA Division of Rheumatology Los Angeles California 90095 —
Harbor UCLA Medical Center Torrance California 90509 —
University of CT Farmington Connecticut 06030 —
Department of Rheumatology Washington D.C. District of Columbia 20007 —
University of Florida Jacksonville Florida 32209 —
Rheumatology, MC 733, The University of Illinois-Chicago Chicago Illinois 60612 —
John Hopkins, Division of Rheumatology Baltimore Maryland 21224 —
Boston University School of Medicine Boston Massachusetts 02118 —
University of Michigan Scleroderma Program Ann Arbor Michigan 48106 —
Michigan State University Grand Rapids Michigan 49546 —
University of Minnesota Minneapolis Minnesota 55455 —
Mayo Clinic - Division of Rheumatology Rochester Minnesota 55905 —
The Center for Rheumatology Albany New York 12206 —
Division of Rheumatology and Allergy - Clinical Immunology Lake Success New York 11042 —
AAIR Research Center Rochester New York 14618 —
Carolina Arthritis Wilmington North Carolina 28401 —
Chief of Rheumatology Toledo Ohio 43614 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
Medical University of South Carolina, Division of Rheumatolgoy and Immunology Charleston South Carolina 29425 —
Department of Critical Care - Virginia Mason Medical Center Seattle Washington 98101 —
Arthritis Northwest Spokane Washington 99204 —
Medical College of Wisconsin and Froedtert Hospital Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00706082, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2012 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00706082 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →